Format

Send to

Choose Destination
West J Med. 2000 Sep;173(3):175-9.

Achieving further glycemic control in type 2 diabetes mellitus.

Author information

1
Kaiser Permanente Center for Health Research, 3800 N Interstate Ave, Portland, OR 97227, USA. greg.nichols@kp.org

Abstract

OBJECTIVES:

To identify patients with type 2 diabetes mellitus who were in poor glycemic control and therapeutic adjustments that might improve control.

DESIGN:

Using electronic pharmacy data, we assigned subjects to 1 of 4 therapeutic categories. We then identified patients within each category who did not meet the recommended standard of glycemic control (glycosylated hemoglobin [Hb A(1c)] <0. 08 [<8.0%]) and studied their therapetic regimens for possible improvements.

SUBJECTS:

The subjects were 5,061 members of a large group-model health maintenance organization who had type 2 diabetes and 12 months of 1997 health plan eligibility. Main outcome measures The dosage of antihyperglycemic agents (sulfonylureas, metformin, and insulin) in relation to glycemic control as measured by the Hb A(1c).

RESULTS:

A significant number (n = 1,570 [31.0%]) of persons with type 2 diabetes might improve their glycemic control with simple adjustments to their pharmacologic therapy.

CONCLUSION:

Busy clinicians with heavy workloads can improve their management of diabetes by identifying patients whose glycemic control could be improved through a change in medication or simple adjustment in dosage.

PMID:
10986179
PMCID:
PMC1071057
DOI:
10.1136/ewjm.173.3.175
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center